Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Elena N.
Elena N. Demchuk, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080313210 | Content Publishing Customized to Capabilities of Device - Aspects of the subject matter described herein relate to customizing content to the capabilities of a device. In aspects, an editor uses an editorial tool to specify criteria applicable to content. The criteria include rules to apply in generating content based on quantized capabilities of devices. A publishing component that receives a request for content first detects the capabilities of the requesting device. Then, the publishing component classifies the capabilities of the device and applies the criteria to the classifications in customizing content to deliver to the device. | 12-18-2008 |
Elena N. Klyushnenkova, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20080219972 | Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer - A nucleic acid molecule comprising at least one nucleotide sequence encoding SEQ ID NO: 14, 15, 19, 41, or a sequence that is at least about 95% identical thereto; a composition comprising same and a method of administering same to induce an immune response; a polypeptide consisting of SEQ ID NO: 14, 15, 19, 41, or a sequence that is at least about 95% identical thereto; a composition comprising same and a method of administering same to induce an immune response; a composition comprising APC, which have been exposed to the polypeptide, and a method of administering same to treat prostate cancer; a composition comprising T-cells, which are specific for an epitope in a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41 and a method of administering same to treat prostate cancer; a composition comprising an anti-idiotypic antibody having an internal image of an epitope of a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41 and a method of administering same to treat prostate cancer; and an immortal B-cell line that produces an anti-idiotypic monoclonal antibody having an internal image of an epitope of a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41. | 09-11-2008 |
| 20080260760 | Prostate-Specific Antigen-Derived Mhc Class H-Restricted Peptides and Their Use in Vaccines to Treat or Prevent Prostate Cancer - The present invention relates to immunogenic peptides derived from human prostate cancer antigen (PSA-derived peptides) and their use as vaccines to treat or prevent prostate cancer. The invention is also related to dendritic cells from a patient having prostate cancer, which dendritic cells have been exposed to one or more PSA-derived peptides, and their use to treat or prevent prostate cancer in the patient. The invention is also directed to T-cells from a patient which cells are specific for PSA-activated peptide(s), and their uses to treat or prevent prostate cancer. | 10-23-2008 |
Elena N. Pokatayev, Muskego, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20120109342 | Wireless Industrial Control User Interface With Configurable Software Capabilities - A user interface operable to connect to a device within an industrial control system includes a memory and a processing unit. The memory is operable to store a plurality of software applications for interfacing with the device and a configuration mask including access rights for at least a subset of the software applications. The processing unit is operable to establish a first connection with the device and disable selected software applications based on the configuration mask. | 05-03-2012 |
Elena N. Pugacheva, Morgantown, WV US
| Patent application number | Description | Published |
|---|---|---|
| 20090306183 | Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation - Compositions and methods are provided for identifying agents which have efficacy for the treatment of disorders related to aberrant cilial structure and function, including polycystic kidney disease. | 12-10-2009 |
| 20100137409 | Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation - Compositions and methods are provided for identifying agents which have efficacy for the treatment of disorders related to aberrant cilial structure and function, including polycystic kidney disease. | 06-03-2010 |
Elena N. Sidorenko, Moscow RU
| Patent application number | Description | Published |
|---|---|---|
| 20090191394 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof - The present invention is related to the synthesis of acenaphthoquinoxaline sulfonamide derivatives and the manufacture of optical crystal films based on these compounds. Said acenaphthoquinoxaline sulfonamide heterocyclic derivatives have the general structural formula: where n is 1, 2 or 3; X is an acid group; m is 1, 2 or 3; Y is a counterion selected from the list consisting of H | 07-30-2009 |
| 20100039705 | Organic Compound, Anisotropic Optical Film and Method of Production Thereof - The present invention is related to 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of the general structural formula (I), the anisotropic optical film based on these derivatives with phase-retarding properties for displays, and method of producing thereof (I) where X is a carboxylic group COOH, m is 0, 1, 2 or 3; Y is a sulfonic group SO | 02-18-2010 |
| 20100047477 | 6,7-Dihydrobenzimidazo[1,2-c]Quinazolin-6-One Carboxylic Acids, their Esters, and Methods of Synthesis Thereof - The present invention relates to a 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acid and its esters of the general structural formula (I), and provides a method for their synthesis (I) where R and each R′ are selected independently from the list comprising —H—CH | 02-25-2010 |